Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for sedation support in mechanically ventilated ICU patients
IRCT20240929063203N11Phase 3Recruiting
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Sedation level, Morphine requirement and 4 more. Started Jul 2026; status: recruiting.
02
Drugs
pregabalin
Beyond the preview
Go deeper on IRCT20240929063203N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N11.